|
市場調査レポート
商品コード
1172032
リアルワールドデータ(RWD)の世界市場:情報源別、用途別、エンドユーザー別 - 予測(~2029年)Real-world Data (RWD) by Source (EMR, Claims, Pharmacy, Disease Registries), Application [Market Access, Drug Development & Approvals (Oncology, Neurology), Post Market Surveillance], and End User (Pharma, Payers, Providers) - Global Forecast to 2029 |
||||||
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。 |
リアルワールドデータ(RWD)の世界市場:情報源別、用途別、エンドユーザー別 - 予測(~2029年) |
出版日: 2022年12月13日
発行: Meticulous Research
ページ情報: 英文 203 Pages
納期: 即納可能
|
世界のリアルワールドデータ(RWD)の市場規模は、2022年から2029年の予測期間中に7.4%のCAGRで成長し、2029年には16億6,000万米ドルに達すると予測されています。市場の成長を後押しする主な要因には、慢性疾患の負担増加、医薬品開発の遅れとそれに伴う開発費の増加、個別化医療への注目の高まり、価値に基づく医療へのシフト、ヘルスケア分野におけるビッグデータの急速な拡大などが挙げられます。
当レポートでは、世界のリアルワールドデータ(RWD)市場を調査しており、市場の概要、市場規模や予測、動向、促進要因・抑制要因、競合情勢、情報源別・用途別・エンドユーザー別・地域別の分析、および企業プロファイルなどを提供しています。
The real-world data (RWD) market is expected to grow at a CAGR of 7.4% from 2022 to 2029 to reach $1.66 billion by 2029.
Following a detailed secondary and primary research and an in-depth analysis of the market scenario, the report provides the key drivers, restraints, challenges, and opportunities in the real-world data (RWD) market.
The growing burden of chronic diseases, delays in drug development and the consequent increase in development costs, the rising attention towards personalized healthcare, the shift toward value-based care, and rapidly growing big data in the healthcare sector are the major drivers for the real-world data (RWD) market. However, the lack of standardized methodologies for developing real-world data solutions is a major challenge for market growth.
Based on source, the pharmacy data segment is slated to register the CAGR during the forecast period. The increasing focus on e-prescriptions and the volume of pharmacy data can serve as real-world data sources to help guide sales and market access strategy, provide data-driven insights to aid the payers' and HTAs' decision-making, maximize payer coverage, and improve patient outcomes.
Based on application, the drug development & approvals segment is slated to register the highest CAGR during the forecast period. RWD can be applied in drug development to support label expansion, optimize clinical use to support label revisions and meet postmarketing information and safety monitoring requirements. RWD insights can help accelerate the drug development & approvals process in a manner aligned with the interests of all stakeholders. Thus, the effective deployment of RWD can accelerate the pace of discovery, enable drug approvals, and help understand the impact of new therapies, thereby boosting the market's growth.
Based on end user, the pharmaceutical, biotechnology, and medical device companies segment is slated to register the highest CAGR during the forecast period. The increasing importance of real-world data studies in drug development & approvals and the growing need to avoid costly drug recalls and assess drug performance in real-world settings are driving the growth of this segment.
Based on geography, North America is expected to grow with the highest CAGR during the forecast period. The growth of this regional market is attributed to the increasing prevalence of chronic diseases, stringent regulations for drug approvals, implementation of the 21st Century Cures Act, availability of electronic datasets, the region's well-developed healthcare industry, and the increasing utilization of big data in healthcare.
Some of the key companies operating in the global RWD market are Elevance Health, Inc. (U.S.), IQVIA Holdings Inc. (U.S.), ICON plc (Ireland), PPD Inc. (U.S.), Clinigen Group plc (U.K.), Cognizant Technology Solutions Corporation (U.S.), Oracle Corporation (U.S.), PAREXEL International Corporation (U.S.), PerkinElmer, Inc. (U.S.), SAS Institute Inc. (U.S.), UnitedHealth Group Incorporated (U.S.), and Flatiron Health, Inc. (U.S.).
Global Real-world Data Market, by Source
Note: Other sources include data gathered from other sources, such as mobile devices, wearable devices, and social media, which can provide information on health status.
Global Real-world Data Market, by Application
Note: Other Therapeutic Areas include infectious diseases, musculoskeletal disorders, dermatological diseases, and respiratory diseases.
Global Real-world Data Market, by End User
Note: Other end users include academic research institutions, patient advocacy groups, regulators, and health technology assessment agencies.
Global Real-world Data Market, by Geography